Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ·Healthcare·Biotechnology
$21.50
+0.02%
Mkt Cap $2.22B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $49.85M | $53.71M | +7.75% | -$0.17 | -$0.20 | -17.65% | — | — |
| Q4 2025 Nov 4, 2025 | $38.20M | $39.80M | +4.18% | -$0.28 | -$0.19 | +31.75% | — | — |
| Q3 2025 Aug 5, 2025 | $39.63M | $33.91M | -14.44% | -$0.35 | -$0.29 | +17.14% | — | — |
| Q2 2025 May 6, 2025 | $36.54M | $30.76M | -15.81% | -$0.46 | -$0.35 | +23.91% | — | — |
| Q1 2025 Feb 25, 2025 | $30.27M | $29.21M | -3.52% | -$0.35 | -$0.69 | -97.14% | — | — |
| Q4 2024 Oct 30, 2024 | $28.48M | $93.76M | +229.17% | -$0.41 | $0.38 | +192.68% | — | — |
| Q3 2024 Jul 30, 2024 | $1.03M | $8.19M | +698.25% | -$0.67 | -$0.05 | +92.54% | — | — |
| Q2 2024 May 6, 2024 | — | — | — | -$0.67 | -$0.72 | -7.46% | — | — |
| Q1 2024 Feb 26, 2024 | — | $560.00K | — | -$0.57 | -$0.64 | -12.28% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$0.60 | -$0.54 | +10.00% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$0.60 | -$0.61 | -1.67% | — | — |
| Q2 2023 May 1, 2023 | — | — | — | -$0.60 | -$0.59 | +1.67% | — | — |
| Q1 2023 Mar 6, 2023 | — | — | — | -$0.57 | -$0.56 | +1.75% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.53 | -$0.53 | +0.00% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.49 | -$0.60 | -22.45% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.39 | -$0.48 | -23.08% | — | — |
| Q1 2022 Mar 7, 2022 | — | — | — | -$0.36 | -$0.36 | +0.00% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.28 | -$0.33 | -17.86% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.31 | -$5.04 | -1525.81% | — | — |
| Q2 2021 May 27, 2021 | — | — | — | — | -$0.56 | — | — | — |